13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 3 managers

Reported value

$5.01M

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$1.3M

Price effect on 3 books still in the name

Largest holder

$4.57M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC617.8K$4.57M−$1.2MCut−$1.11M
Henshaw Capital LLC30.1K$222.8K−$44.1KAdded$14.9K
Leonteq Securities AG29K$214.6K−$57.7KCut−$161K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.